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Abstract 
Objective: To determine the proportion of 50-75-year-old patients of primary care physicians (PCP) 
who were tested for colorectal cancer (CRC) by either colonoscopy within 10 years or fecal occult 
blood testing (FOBT) within 2 years. To describe the variation in care between PCPs and factors 
associated with these proportions. 
Methods: Cross-sectional study between April and December 2017. Participants: PCPs reporting 
for the Swiss Sentinel Surveillance Network. Each PCP collected demographic data and CRC test-
ing status from 40 consecutive patients. Measurements: proportions of patients up-to-date with 
CRC screening and method used (colonoscopy/FOBT/Other); variation in the outcome measures 
between PCPs; association of physician-level factors with main outcomes. 
Results: 91/129 PCPs collected data from 3,451 patients; 45% had been tested for CRC within rec-
ommended intervals (41% colonoscopy, 4% FOBT). The proportions of patients tested and testing 
with colonoscopy vs. FOBT varied widely between PCPs. Language region was associated with 
PCPs’ rate of FOBT prescription.  
Conclusion: Less than half of patients who visited PCPs in Switzerland were up-to-date with CRC 
screening recommendations. PCPs varied widely in their testing practices. 
Introduction 
Screening for colorectal cancer (CRC) is recommended for those over 50 at average-risk of CRC, 
based on evidence from randomized controlled trials and observational studies that CRC screening 
substantially reduces CRC mortality and decreases incidence. (Brenner et al. 2014; Dominic et al. 
2009; Lauby-Secretan et al. 2018; USPSTF 2016; von Karsa et al. 2013) Fewer people in Europe 
are screened for CRC than in the US. (Chen et al. 2017; Klabunde et al. 2015; Stock and Brenner 
2010) In Switzerland, the 2012 national health survey found that only 40% of 50-75 year-olds were 
up-to-date with screening at recommended intervals: colonoscopy in the last 10 years (26%), or 
fecal occult blood test (FOBT) in the last 2 years (7%), or both (7%). (Braun et al. Under review; 
Fedewa et al. 2015) 
While European guidelines recommend organized screening programs for CRC, many countries, 
including Switzerland, have not yet implemented programs at a national level. (Schreuders et al. 
2015) In July 2013 universal basic health insurance started reimbursing CRC screening with FOBT 
and colonoscopy for those aged 50-69 in Switzerland. In 2015, the first organized, state wide, 
screening program in Switzerland began first in the canton of Vaud and expanded to Uri; the pro-
grams target residents between the ages of 50 and 69 and participants have their insurance de-
ductible waived. Over the next few years, the target population (N=170’000) of the canton of Vaud 
will be sent individual invitations with a decision aid for CRC screening, and invited to discuss CRC 
screening with their family physician. (Auer et al. 2015) The Vaud program offers each eligible citi-
zen the chance to (a) make an informed choice with their family physician to screen for CRC; and 
(b) to choose between FOBT and colonoscopy. CRC screening is opportunistic and mostly initiated 
in primary care for most other Swiss citizens, comparable to the U.S. 
One of the most advanced FOBTs is the fecal immunochemical test (FIT), also called immunologi-
cal FOBT (iFOBT). FIT can detect CRC at a rate similar to colonoscopy, but they cannot detect as 
many polyps or advanced polyps as colonoscopies. (Salas et al. 2014)  Recent modelling from 
CISNET suggests that the absolute number of lifetime CRC deaths averted by a yearly FIT is 23 
per 1000 individuals screened; colonoscopy once a decade averts 25 per 1000 CRC deaths 
(Knudsen et al. 2016), but it is an invasive procedure with rare but serious adverse effects. Pa-
tients must take a time off work for a colonoscopy, prepare their bowels (an unpleasant process for 
most), and endure the exam itself. Patients who choose FIT can avoid these requirements, but 
must sample their own stool at home and mail the test to the laboratory. Patients who use FIT must 
undergo colonoscopy only if blood is detected in the stool sample (6-8% of samples in average risk 
populations). In a context where CRC screening is essentially based on screening with colonos-
copy, offering the choice of FIT to patients in addition to colonoscopy may increase CRC screening 
overall.(Inadomi et al. 2012)  
There is little international data on variations in care between primary care physicians’ (PCP) prac-
tices that offer or recommend CRC tests to patients, but evidence from Switzerland and the US 
suggests most PCPs prescribe only colonoscopy, and few prescribe FOBT. (Selby et al. 2016; 
Weiss et al. 2013) There may be a mismatch between what patients are offered and what they 
may prefer. (Hawley et al. 2014) In an RCT in primary care practices in the US, when patients were 
offered only colonoscopy, only 38% were screened, but when they were offered only an FOBT, 
67% were screened. When both FOBT and colonoscopy were offered, 69% were screened, and a 
roughly equal number of patients opted for each test. (Inadomi et al. 2012) Recent guidelines from 
the US Services Preventive Task Force (USPSTF) highlighted the difficulty of balancing between 
risks and benefits of CRC screening options. Since the options are variably acceptable to patients 
and because offering FIT in addition to colonoscopy might increase overall screening rates, the 
guideline suggested PCPs share decision with their patients to elicit their patient’s preferences and 
increase adherence to screening. (USPSTF 2016)  The role of “well-supported and unhurried con-
versations between physicians and patients” about CRC screening options was recently high-
lighted in a review that discussed ethical issues in the design and implementation of population-
based health programs.(DeCamp et al. 2018)  
We set out to determine overall testing rates and method of CRC testing among patients 50-75 
years old who visited a representative sample of PCPs participating in the Swiss Sentinel Surveil-
lance Network (Sentinella). We wanted to identify the proportion of tested for CRC within the speci-
fied time period (colonoscopy within 10 years, or FOBT within 2 years), and the method with which 
they had been tested (colonoscopy/FOBT/other), describe variations in CRC testing between phy-
sicians, and to determine the physician-level factors associated with those proportions and meth-
ods. 
Method 
Study Setting and Data Collection 
The Swiss Sentinel Surveillance (Sentinella) network is a cooperative surveillance project of the 
Federal Office of Public Health (FOPH). A convenience sample of 150 to 250 general practitioners, 
internists, and pediatricians in private practices voluntarily report weekly morbidity data to the net-
work. Participating PCPs report irreversibly anonymized patient data collected during consulta-
tions. The number of participating Physicians varies from year to year. In 2017 there were 129 
Physicians reporting data for Sentinella (pediatricians excluded), who were invited to participate in 
our data collection. We used a paper data collection form that we developed with PCPs and spe-
cialist physicians in public health and epidemiology. We refined the form in a pilot test with 10 
PCPs. The design is based on a comprehensible algorithm that limits the amount of data collected 
to fit the routine and busy schedule of PCPs. To ease and standardize data collection, we gave 
PCPs examples of completed data collection forms, short summaries, and showed them an 8-mi-
nute online instruction video (French and German only) that explained the data collection process. 
Following the usual process of collecting data in Sentinella, we sent the form to the FOPH, which 
distributed it to participating primary care practices in April 2017. PCPs were asked to collect data 
as soon as possible, but could choose when to start. In practices where more than one PCP re-
ported to the Sentinella network, we asked that only one collect data. Completed forms were sent 
to the FOPH, which transferred them to us, ensuring the data was twice anonymized and de-identi-
fied when necessary. Data collection was complete at the end of December 2017. 
The ethics committee of the canton of Bern waived ethical approval for the study because of the 
double irreversible patient-data anonymization process (the FOPH cannot identify the patients, and 
investigators cannot identify the PCPs), so our study fell outside of the scope of the Swiss Human 
Research Act (REQ-2017-00280). 
Measures, Outcomes and Covariates 
Physicians were asked to systematically include 40 consecutive patients, aged 50-75 years, seen 
for a non-urgent face-to-face consultation for more than 5 minutes. PCPs had to follow a strict al-
gorithm for reporting patient data (Online Resource 2) on the collection form. It was up to the PCPs 
to gather the data on previous CRC testing, either by reviewing the medical records, by asking pa-
tients directly during the visit, or both. PCPs who felt overburdened with including every consecu-
tive patient who met the inclusion criteria could choose to include only the first two eligible patients 
per half-day of work, spreading data collection over a longer period of time. This study is con-
cerned with answers to the first section of the form, where PCPs reported patients’ age (birth year 
only), sex (male, female), and previous CRC testing (colonoscopy < or > 10 years, FOBT < or > 2 
years, other tests, no tests or unknown).  The data form only asked PCPs to report if tests had al-
ready been performed, and did not ask PCPs to distinguish between diagnostic or screening tests 
since diagnostic CRC tests can also have a preventive effect, and a test for either reason would 
qualify as meeting recommendations on testing intervals.(Stock et al. 2011) The data form included 
no option to code both a colonoscopy and FOBT if patients had had both examinations within the 
recommended time intervals. The PCP decided which test to prioritize. For previous FOBT testing, 
we did not ask PCPs to distinguish between guaiac based FOBT (gFOBT) and immunological 
FOBT (iFOBT, or FIT) on the data collection form. PCPs also reported the number of weeks it took 
them to collect data on 40 patients. PCPs indicated if patients had already be seen during data col-
lection. If patients had already been seen, we excluded additional visits from our analysis to ensure 
we did not include the same patient more than once.  
The FOPH gave us PCP-level data, including sex, age (30-39, 40-49, 50-59 and >60), language 
region (German, French, Italian), and practice location defined according to size, population den-
sity, and accessibility criteria by the Federal Statistics Office (urban, intermediate, rural). (Federal 
Statistics Office 2017)  
Statistical analyses 
We applied descriptive statistics to present the sample of participating PCPs and the patients they 
included. We calculated overall proportions of a) patients tested for CRC and b) method by which 
they were tested. We also calculated the proportion within each PCP practice of a) patients tested 
for CRC within the specified time periods, and b) testing method used. Then we compared propor-
tions between PCPs. We reported the variation between PCPs in range and quartiles of a) propor-
tion of tested patients, and b) proportion of FOBT among all tested patients. 
We used two multivariate mixed effects logistic regressions models to measure the association be-
tween PCP demographics and a) proportion of patients tested with colonoscopy within 10 years or FOBT 
within 2 years compared to no testing and b) FOBT within 2 years or not. The models allow for the 
clustering of data by PCP. We modeled a random effect by PCP. We modeled fixed effects for pa-
tient characteristics (age and sex) and PCP characteristics (age, sex, language region, practice lo-
cation). 
PCPs’ representativeness was determined by comparing their demographic characteristics to a 
representative Swiss sample of 200 PCPs, also used to develop the Swiss Primary Care Active 
Monitoring (SPAM) program (Selby et al. 2015). We analyzed only available data and did not use 
specific statistical methods to impute missing data. 
All analyses were conducted with Stata version 14.2 (StataCorp LP, College Station, TX, USA).  
 
Results 
Of 129 PCP practices reporting for Sentinella on adult patients, 99 (77%) had a PCP who agreed 
to collect data. We excluded data from eight PCPs because two reported data on 20 or fewer pa-
tients, four did not fill out the data collection form correctly, one did not include patients as pre-
specified, and one had missing sociodemographic characteristics. We included 91 PCPs (71%) in 
our analysis. Most PCPs (N=75) indicated they consecutively included all patients that met the in-
clusion criteria; 14 said they included the first two patients per half-day of work, and 2 did not indi-
cate how they included patients. Mean age of PCPs was 54; three out of four PCPs were men. Half 
worked in urban regions and two-thirds worked in the German-speaking part of Switzerland. Of the 
32 PCPs working in French or Italian speaking regions, 15 participated in the organized CRC 
screening program in Vaud. Compared to a list of Swiss medical associations of 200 PCPs (Selby 
et al. 2015), participating PCPs tended to come from more urban (p=0.02) practices, and from 
French-Italian language regions (p=0.02).  Sociodemographic characteristics of the participating 
PCPs are summarized in Table 1. 
  
Table 1 - Sociodemographic characteristics of participating PCP in the 
2017 systematic data collection in the Sentinella Network in Switzerland 
and comparative data from a list of Swiss medical associations of pri-
mary care physicians (PCPs) (Selby et al. 2015). 
 Participating 
PCPs 
N=91 (%) 
Comparison 
sample 
N=200 (%) 
P value a 
    
Age (years)    
30-39 5 (5)   
40-49 16 (17)   
50-59 27 (29)   
>60 43 (47)   
    
Mean age (SD) 54 (10) 53† (7) 0.14 
    
Sex   0.51 
Female 22 (24) 42 (21)  
    
Area   0.02 
Urban 47 (52) 70 (35)  
Intermediate 22 (24) 76 (38)  
Rural 22 (24) 54 (27)  
    
Language   0.02 
German 59 (65) 152 (76)  
French 27 (30) 46 (23)  
Italian 5 (5) 2 (1)  
a P-value for mean age generated with two-sample t-test. P-value for 
sex, age, and language generated with chi2 test.  
† Age estimated by adding 25 years to the year when participants re-
ceived their medical school diploma. 
 
PCP collected data on 3,637 patients. Of these, we excluded 142 patients because they were not 
50-75 years old, and 44 because they had already been seen and included during data collection.  
Age, gender and CRC testing status of the 3,451 included patients are summarized in Table 2.  
Mean age of the patients was 63 years, 50% were male. Half the population was not up-to-date 
with CRC screening recommendations; 41% had been tested with colonoscopy within the last 10 
years, 4% with FOBT within the last 2 years, 1% had had another test and screening status was 
missing for 4% of patients (Fig. 1).  
  
Table 2 - Patient characteristics and colorectal cancer (CRC) testing proportions in the 2017 systematic data 
collection in the Sentinella Network in Switzerland. 
 Men 
N=1,709 (%) 
Women  
N=1,742 (%) 
Total 
N=3,451 (%) 
    
Age (years)    
50-59 639 (37) 653 (37) 1,292 (37) 
60-69 667 (39) 692 (40) 1,359 (40) 
70-75 403 (24) 397 (23) 800 (23) 
    
Mean (SD) 62.7 (7) 62.7 (7) 62.7 (7) 
    
CRC testing status (%)    
No up-to-date examination 878 (51) 847 (49) 1,725 (50) 
Colonoscopy < 10 years 672 (39) 733 (42) 1,405 (41) 
FOBT < 2 years 71 (4) 80 (5) 151 (4) 
Other test 16 (1) 12 (1) 28 (1) 
Unknown 72 (4) 70 (4) 142 (4) 
 
 
Figure 1 - Proportion of patients not up to date with colorectal cancer (CRC) testing, tested for CRC by co-
lonoscopy within the last 10 years, fecal occult blood test (FOBT) within the past 2 years, or other test. Sys-
tematic data collection in the Sentinella Network in Switzerland in 2017. 
 
 
Median proportion of patients tested for CRC within the specified time period per PCP (N=91) was 
45% (mean 46%, range 8%-86%, IQR: 36%-57%). See Fig. 2, Panel A for variation between PCPs 
in the proportion of patients they tested for CRC. The proportion of patients tested with FOBT 
among all tested patients per PCP is shown in Fig. 2, Panel B. 54 PCPs (59%) had no patients 
tested with FOBT. The median proportion of patients tested with FOBT within 2 years per PCP 
(N=91) was 0% (Range 0%-90.9%, IQR: 0%-10%). In multivariate adjusted analyses, older pa-
tients were more likely to have been tested for CRC (Table 3). Patients seen by PCPs in the 
French- or- Italian-speaking part of Switzerland were more likely than those from the German-
speaking part of Switzerland to have been tested with FOBT then to have had no FOBT testing 
(Table 4).  
 
Figure 2 - Proportion of patients tested for colorectal cancer (CRC) within each primary care physician (PCP) 
practice (Panel A) and proportion of patients tested with fecal occult blood test (FOBT) among all tested 
patients within each PCP practice (Number of PCPs with at least one patient tested with FOBT: 37/91) 
(Panel B). Systematic data collection in the Sentinella Network in Switzerland in 2017. 
 
  
Table 1 – Covariates associated with previous colorectal cancer (CRC) testing of 40 consecutive 
patients within each primary care physician (PCP) practice that collected data during the 2017 
systematic data collection in the Sentinella Network in Switzerland (N PCPs=91, N pa-
tients=3451).a 
 OR 95% CI P Value 
    
Age PCP (ref: 30-39 years)    
   40 - 49 1.42 0.66 to 3.04 0.37 
   50 - 59 0.95 0.47 to 1.93 0.88 
   > 60 0.92 0.47 to 1.82 0.82 
    
Sex PCP (ref: male)    
Female 1.01 0.71 to 1.43 0.96 
    
Language Region (ref: German)    
French / Italian 1.07 0.78 to 1.48 0.66 
    
Practice Location (ref: Urban)    
Intermediate 1.05 0.69 to 1.58 0.81 
Rural 0.67 0.41 to 1.11  0.12 
    
Age Patients (ref: 50-59 years) 
   60-69 
   70-75 
 
1.87 
2.44 
 
1.58 to 2.20 
2.01 to 2.95 
 
<0.01 
<0.01 
    
Sex Patients (ref: male) 
   Female 
 
1.08 
 
0.94 to 1.25 
 
0.28 
a Results from a multivariate mixed effects logistic regression model with previous CRC testing with colonos-
copy within the last 10 years or FOBT within the last two years as the outcome, a random effect by PCP and 
fixed effects for patient-level and PCP-level covariates listed in the table. 
  
Table 4 – Covariates associated with previous colorectal cancer (CRC) testing with fecal occult blood test 
(FOBT) of 40 consecutive patients  within each primary care physician (PCP) practice  that collected data 
during the 2017 systematic data collection in the Sentinella Network in Switzerland (N PCPs=91, N pa-
tients=3451) .a 
 OR 95% CI P Value 
    
Age PCP (ref: 30-39 years)    
   40 - 49 0.64 0.03 to 12.59 0.77 
   50 - 59 1.23 0.08 to 19.59 0.88 
   > 60 0.92 0.29 to 45.76 0.32 
    
Sex PCP (ref: male)    
Female 0.55 0.14 to 2.22 0.40 
    
Language Region (ref: German)    
French / Italian 8.06 2.38 to 27.35 <0.01 
    
Practice Location (ref: Urban)    
Intermediate 1.30 0.28 to 6.11 0.74 
Rural 0.67 0.08 to 5.59  0.71 
    
Age Patients (ref: 50-59 years) 
   60-69 
   70-75 
 
1.05 
1.18 
 
0.60 to 1.85 
0.65 to 2.16 
 
0.85 
0.59 
    
Sex Patients (ref: male) 
   Female 
 
1.45 
 
0.93 to 2.27 
 
0.1 
a Results from a multivariate mixed effects logistic regression model with previous CRC test-
ing with FOBT within the last 2 years as the outcome, a random effect by PCP and fixed ef-
fects for patient-level and PCP-level covariates listed in the table.  
 
Discussion 
Among patients who visited Swiss primary care practices in 2017, 46% were up-to-date with CRC 
screening; 89% of these were tested with colonoscopy. The proportion of patients tested for CRC 
within the specified time period, and the tests used, varied widely across PCPs. French-or Italian-
speaking physicians, half of whom are involved in the Vaud CRC screening program, used FOBT 
more often than their German-speaking colleagues.  
Among participating PCPs in Switzerland, we found 41% of patients aged 50 to 75 had been 
tested with colonoscopy in the last 10 years. A 2017 meta-analysis reported on endoscopy (colon-
oscopy + sigmoidoscopy) rates worldwide; in the US, rates for lifetime colonoscopy ranged from 
31% to 63% whereas for countries other than the U.S. (Germany, Italy, Spain, the Netherlands, 
Hong Kong, Singapore, South Korea, Switzerland, Canada) rates ranged from 12%–44% for life-
time colonoscopy, and 13–30% for recent colonoscopy (within 5-10 years) (Chen et al. 2017), ex-
cept for Germany where, in 2008–2011, 55% of the screening-eligible population reported colonos-
copies within the last 5 to 10 years.  
Previous studies reported 33% of patients were up-to-date with CRC testing in university primary 
care practices in 2005 and 2006, and 40% were up-to-date according to the 2012 Swiss Health 
Survey (Braun et al. Under review; Fedewa et al. 2015; Fischer et al. 2013), but we found higher 
rates of CRC testing in Switzerland. This difference might be explained by rising rates of CRC test-
ing, especially colonoscopy, in developed countries (Chen et al. 2017); our higher rates may reflect 
this upward trend. Another explanation is that PCPs volunteer to participate in the Sentinella net-
work, and this self-selected group may be more sensitive to public health issues and more inclined 
to discuss and offer CRC tests to their patients. 
Even though our colonoscopy CRC testing rates exceeded those previously reported, we found 
much lower rates of FOBT testing (4%) than were estimated by earlier studies with different de-
signs (13-14%) (Braun et al. Under review; Fedewa et al. 2015; Fischer et al. 2013). The 2017 
meta-analysis did not report information on FOBT but a study in Germany on claims data from 
2000-2008 did. They age-standardized their report on the percentage of individuals who had had 
colonoscopies within ≤10 years and FOBT within the last year and found 23% of men and 26% of 
women were tested with colonoscopy, while and 14% of men and 22% of women were tested with 
FOBT (Stock et al. 2011). A survey of CRC screening programmes worldwide (Klabunde et al. 
2015) showed FOBT uptake rates within the last 2 years of 7-68% and confirms that the rates 
found in our study are low. We posit three main reasons why our reported FOBT rates were lower 
than previously reported. First, until recently, guidelines for CRC screening in Switzerland clearly 
favored colonoscopy and presented FOBT as an inferior option. So we posit that that most PCPs in 
Switzerland still prefer and mainly offer colonoscopy as a screening option. Second, we report on 
previous CRC testing, which includes both CRC diagnostics and CRC screening. Guidelines 
clearly recommend colonoscopy as the preferred to method for ruling out CRC among patients with 
symptoms of CRC and not FOBT. So, the low proportion of FOBT might reflect the fact that pa-
tients might have visited their PCP because they had CRC symptoms or other co-morbidities asso-
ciated with CRC. Previous analyses of the Swiss Health Survey of 2007 and 2012 suggest that 
those who visited a PCP had a higher colonoscopy/FOBT ratio than those who did not visit a PCP 
(Braun et al. Under review; Fedewa et al. 2015). Since we report rates of patients who visited their 
PCP, we expect the proportion of colonoscopy/FOBT to be higher than among the general popula-
tion. Third, some PCPs may have prioritized colonoscopy over FOBT for people who had had both 
tests, since only one could be reported in the notification form. This is why the FOBT rates we rec-
orded might not reflect the true rate for those in the Swiss population who did not visit a PCP prac-
tice. It also might not reflect the true rate among patients who did visit PCPs since some patients 
might have had both an FOBT and a colonoscopy, and may only have reported the colonoscopy. 
This was a weakness of our study design. 
Although both tests are recommended for screening, most PCPs had 0/40 patients tested with 
FOBT and few PCPs had almost all their patients tested with FOBT. If we assume that Swiss pa-
tients can choose between the tests at an equal rate, like US patients (Inadomi et al. 2012), then 
physician preference is likely to be the deciding factor in choice of test rather than patient prefer-
ence. Higher rates of FOBT testing in French- and Italian-speaking regions of Switzerland (15/32 
participating in the CRC screening program in Vaud)  might result from the training given to PCPs 
in the Vaud screening program, since this focuses on offering patients FOBT and colonoscopy on 
an equal basis.(Selby et al. 2016) Informing patients about different screening options in organized 
screening programs, teaching PCPs about available tests and urging them to consider patient pref-
erences could help reduce disparities and variation in care.  
Strengths of this study include the high adherence of PCPs in the Sentinella network, some of 
whom have participated in the network for over 30 years. The Network routinely collects nationwide 
and country representative patient data and has participated in several studies (Gnadinger et al. 
2017; Hurlimann et al. 2015; Schmutz et al. 2017), so Sentinella physicians are practiced in provid-
ing quality data. The data collection form was developed and tested with PCPs, and was based on 
a comprehensible algorithm that limited the amount of data PCPs needed to collect, and standard-
ized data collection between PCPs. These factors and the clear instruction for collecting data, likely 
explain the very low rate of incorrectly completed data forms (4/98). Unlike the Swiss Health Sur-
vey, we did not rely on telephone interviews. Participating physicians could verify CRC testing sta-
tus in medical records. If they needed more information, PCPs could query their patients directly 
about previous CRC testing; patients’ self-reported data on colonoscopy usually matches their 
medical records (Dodou and de Winter 2015). 
Our study was limited by the simplicity and anonymity of the data collected. Since only one type of 
test could be reported, colonoscopy may have been reported more often than FOBT or vice versa 
in patients who had taken both tests. Reporting preference may have differed between PCPs and 
may have been related to their characteristics.  We could not analyze other sociodemographic fac-
tors of patients that could have been associated with CRC testing. Our results only apply to the 
population that visits PCPs, and not to the whole Swiss population. When we compared study par-
ticipants to a random sample on a list from the Swiss Medical Association, we found that PCPs in 
urban areas and those practicing in the French and Italian part of Switzerland were overrepre-
sented. PCPs could not indicate on the data collection form which “other tests” patients might have 
undergone, and thus could not indicate if they were conducted within the recommended time inter-
vals. Since we did not perform a chart-based validation of the data collected, we are unable to as-
sess the quality of the self-report of the data by PCPs. We urge for careful interpretation of the 
data, since we cannot rule out the possibility of selection bias of participants by PCPs who might 
not have strictly followed the consecutive inclusion of patients rule. Even if the participating PCPs 
had experience in rigorously collecting data as a regular reporting activity for the FOPH within the 
Sentinella network, we cannot eliminate the possibility of information bias. Patients might have un-
derreported FOBT and some PCPs may have been more likely than others to verify previous 
screening, introducing bias.  
Since diagnostic CRC tests can have a preventive effect,(Stock et al. 2011) the data collection 
form did not distinguish between tests that had been done for diagnostic or screening purposes, so 
the rate of patients previously tested for CRC is not limited to patients who were tested for screen-
ing purposes. Including all past CRC tests helped us correctly identify the population who had not 
previously been tested for CRC within recommended intervals, and who were thus eligible for CRC 
screening. The data collection form also did not distinguish between previous guaiac-based FOBT 
(gFOBT) and immunological FOBT (iFOBT). 
Future studies should test the effect of interventions promoting shared decision making among 
PCPs to reduce variation in care between PCPs and increase variation within PCP practices for 
screening methods for CRC. We are currently testing a multi-component data-driven training pro-
gram to promote shared decision making in CRC screening decisions. It is intended to increase the 
proportion of patients who opt for screening and increase the number of PCP practices where pa-
tients are tested for FOBT and colonoscopy after making an informed choice.  
Among the PCPs reporting for the Sentinella network in Switzerland, less than half of patients be-
tween 50-75 years old were up-to-date with CRC screening. Most PCPs never tested their patients 
with FOBT; a small number only reported using FOBT. PCP preference may explain the prepon-
derance of colonoscopy tests and the low rate of FOBT and the wide variation in testing rates 
among PCP practices.  
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